LindaCarolLauxMD
Pediatrics • Chicago, ILChild Neurology
Assistant Professor in Pediatrics, Northwestern University Medical School
Dr. Laux is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 E Chicago Ave
#29
Chicago, IL 60611Phone+1 312-227-3540Fax+1 312-227-6940
Education & Training
Phoenix Children's HospitalFellowship, Child Neurology, 1994 - 1997
University of Arizona College of Medicine-TucsonResidency, Pediatrics, 1990 - 1993
Saint Louis University School of MedicineClass of 1990
Certifications & Licensure
IL State Medical License 2000 - 2026
AZ State Medical License 1994 - 2010- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
Clinical Trials
- Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Start of enrollment: 2012 Apr 01
Publications & Presentations
PubMed
- 583 citationsCannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialOrrin Devinsky, Eric D. Marsh, Daniel Friedman, Elizabeth A. Thiele, Linda Laux
The Lancet. Neurology. 2016-03-01 - 110 citationsCannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.Jacqueline S. Gofshteyn, Angus Wilfong, Orrin Devinsky, Judith Bluvstein, Joshi Charuta
Journal of Child Neurology. 2017-01-01 - 512 citationsCannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trialElizabeth A. Thiele, Eric D. Marsh, Jacqueline A French, Maria Mazurkiewicz-Bełdzińska, Selim R Benbadis
Lancet. 2018-03-17
Press Mentions
The Design and Impact of a Hospital-Based Neurodiagnostic Training Program in Electroencephalography and Polysomnography TechnologyAugust 8th, 2024- Antisense Oligonucleotide Shows Potential in Dravet SyndromeDecember 9th, 2022
- Stoke Therapeutics : Presents Data from a Combined Interim Analysis of the Phase 1/2a - Form 8-KDecember 2nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
